Please login to the form below

Not currently logged in

Glyn Edwards appointed interim CEO at the BioIndustry Association

He takes on a leadership role at the UK industry body following the departure of Nigel Gaymond

The UK's BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive.

Edwards was previously CEO at Antisoma from 1998-2011 and prior to this he worked in a variety of business development roles in the biotech and healthcare industries.

Tim Edwards, BIA Chairman, said: “I am delighted that Glyn has been able to join the BIA at this time. Nigel Gaymond has left to pursue other opportunities and I thank him for his engagement with members and his contribution to the BIA over the past two years.

“Glyn's experience as a biotech CEO and a former BIA Board member will be valuable as we continue to develop the BIA.”

Glyn Edwards, BIA interim chief executive, added: “I am looking forward to working with BIA members, its board and staff to help ensure that the UK's life sciences sector is recognised not only here in the UK but also globally.”

24th November 2011


Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare through effective collaboration. Making work to feel proud of.

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...